Search results for: NHS Expenditure
Filter search results
OHE Awarded £457K Grant on Measuring Public Preferences for Health States
2 August 2012
…Value Set for England.[1] Initial findings are expected early next year. Potential applications of the results of the research include the NHS PROMs program; population health surveys; and clinical trials…
Spotlight on OHE: Recent Awards, Publications and Presentations
12 September 2012
…a framework for assessing the value created for patients, the NHS and society. At the 9th European Conference on Health Economics in July, Jorge Mestre-Ferrandiz presented the results of OHE…
Advances in Oncology Modelling: Recent Results from POI Research
18 September 2012
…a group of pharmaceutical companies, all members of the Association of the British Pharmaceutical Industry, that work with and support the NHS in improving the delivery of cancer services. https://www.abpi.org.uk/our-work/value-access/groups/Pages/poi.aspx …
Comparing Prescription Medicines Prices in the UK to Prices in Other Countries
23 October 2012
…England to show what the NHS would pay for medicines if they were priced at the levels in the comparator countries. Additional details on the methodology are explained in the…
Collected Essays by Tony Culyer on Health Economics
25 November 2012
…means for achieving them. The essays in this section illustrate this approach as applied to the NHS, delving into objectives and then assessing the appropriate role of market mechanisms in…
Spotlight on OHE: Understanding Value Based Pricing
12 February 2013
…applications—where he discussed approaches to valuing genomic medicines. The conference was sponsored by the NHS Genetics Education and Development Centre; it focused on opportunities and challenges for translational genomics from…
Review of Plans for Refining Patient-Reported Outcomes Measures
19 February 2013
… [1] The POI is a group of pharmaceutical companies, all members of the Association of the British Pharmaceutical Industry, that work with and support the NHS in improving the delivery of…
NICE Decisions: Exploring the Influence of Cost-Effectiveness and Other Factors
30 April 2013
…for Health and Clinical Excellence (NICE) undertakes appraisals of selected technologies and issues guidance intended to ensure quality and value for money. Its decisions are binding within the NHS and…
OHE’s Towse on Challenges in Valuing Genomic Medicines
23 May 2013
…view other videos from the Translation Genomics Event presented by the NHS’s National Genetics Education and Development Centre click here. Challenges in Valuing Genomic Medicines from Office of Health Economics…